not occur. When 11 months old he died of intercurrent respiratory infection. The findings at necropsy were similar to the case reported by Holleman et al. (1966) .
Laboratory data. Raised serum levels of transaminases, aldolase, lactate dehydrogenase, especially iso-enzyme V, were present. Total fatty acids, cholesterol, paper electrophoresis of the lipoproteins, and the fatty acid content of the serum lipids were normal. Immunoelectrophoresis showed a normal pattern. PBI was normal (6*4 ,ug./100 ml.). As there was muscular hypotonia the serum creatine phosphokinase activity was estimated; values of 0 8 and 1 -4 U/ml. * were recorded (normal < 1); EMG of quadriceps muscle femorus was normal. ECG, normal.
Methods
Liver biopsy. Liver tissue was obtained by needle biopsy after an 8-hour-fast, using the technique of Menghini (1958) ; vitamin K was given prophylactically. Four biopsies were performed, none of which was followed by bleeding. The specimen was immediately cut in three parts, one being frozen for biochemical examination, the other two fixed in ethanol 96% and formalin 10%, respectively. Leucocyte isolation. Leucocytes were isolated by the 'film' technique. The cells were homogenized and centrifuged and the protein content of the 14,000 xg supernatant determined (Huijing, 1964 (Huijing, , 1968 . Phosphorylase activity (Huijing, 1964) , and the activity of the debranching enzyme system with the aid of glucose oxidase (Huijing, Klein Obbink, and van Creveld, 1968) were determined.
Branching enzyme. The activity of branching enzyme in leucocytes was determined by the method of Brown and Brown (1966) , measuring the increase in phosphate production from glucose 1-phosphate by phosphorylase in the absence of added primer. As can be seen from Fig. 1 x reagent set TC-B). Plasma NEFA was estimated with a micro-modification of Dole's method (Trout, Estes, and Friedberg, 1960; Fernandes and van de Kamer, 1965 It can be seen from Fig. 1 that extract of the -Branching enzyme activity in leucocytes. 20 leucocytes of patient P.V. caused no increase over ilglycine, 4 mM AMP, 20 mM 2-mercaptoethanol, the rate of phosphate production in the control 00 ,ug. phosphorylase a (4 x crystallized, purified tube. RE-cellulose), leucocyte protein (14,000 x g superThe Table shows that leucocyte extracts of normal nd 80 mM glucose 1-phosphate were incubated in children, and of patients with a debranching enzyme fume of 0 75 ml. at pH 6-4 at 300 C., according deficiency or a low activity of phosphorylase kinase X and Brown (1966) . At 15-minute intervals (Huijing, 1968) , show activities of branching enzyme Z was determined in 0 10 ml. aliquots. A within the same range as normal adults. On 3 tube containing 0-25 utmole ofphosphate gave an different occasions negligible activity was found in extinction at 700 m,u~of 0-420.extinctio at70a leucocyte extract of patient P.V. A mixture of normal leucocyte extract and that of the patient *n ilo n e ien showed the same activity as the extract of normal ted from liver tissue of leucocyte extracts with leuco KOH. It was precipitated with ethanol, accytes alone. The activtes of phosphorylase L , and determined with the phenol sulphuric and the debranching enzyme system in leucocytes iod of Dubois et al. (1956 Park and Johnson (1949) after deproteinization with Ba(OH)2 and ZnSO4. Blood fructose was estimated according to Zender and Falbriard (1966) , and lactate with L-lactate dehydrogenase (Boehringer Glycogen structure. No extensive experiments to determine the structure of the glycogen in the tissues of the patient were carried out. However, 58% ofthe glucose 1-phosphate that could be released by phosphorylase+the debranching enzyme system, was released by pure phosphorylase b alone, compared with 35% with a control glycogen. This pointed to the fact that the branches were long. The enzymatic degradation was followed spectrophotometrically at 340 m,u in a final volume of 1 ml. containing 80 mM sodium phosphate buffer (pH 6 5), 2 mM EDTA, 10 mM MgCl2, 2 mM AMP, 0 2 mM NADP+, approximately 10 t±g. of glycogen and excess phosphoglucomutase, glucose o0 --resulted in a normal increase in blood glucose concentration and a decrease in NEFA (Fig. 4) .
When the test was repeated at 91 months, no response was observed (Fig. 4) . Treatment Diet therapy. A high-protein, low-carbohydrate diet with corn oil added to the milkfat was given, but resulted in no effect either on weight gain or on the progression of the cirrhotic process.
Treatment with o-glucosidase. According to current ideas, the cirrhosis of the liver is caused by accumulation of the amylopectin-like glycogen. We therefore tried to mobilize this 'toxic' glycogen. Baudhuin, Hers, and Loeb (1964) showed that intramuscular administration of purified fungal oc-glucosidase to a patient with type II glycogenosis (lysosomal acid ax-glucosidase deficiency) decreased the glycogen concentration of the liver from 11 * 5 to 8%. Cuthbertson, Fleming, and Rice (1967) showed that this enzyme, when injected intraperitoneally in the rat, was rapidly taken up in several tissues, and that raised levels of x-glucosidase could be detected in the liver for as long as 4 days.
Before treating our patient with oc-glucosidase, some preliminary experiments were carried out. Highly purified oc-glucosidase from Aspergillus niger prepared as described by Abdullah et al. (1963) was generously provided by Prof. W. J. Whelan (Dept. of Biochemistry, Royal Free Hospital School of Medicine, London W.C.1). We were able to show that this enzyme could degrade glycogen isolated from the patient's leucocytes.
In liver tissue from the patient, obtained by needle biopsy, the glycogen concentration was 107 ,ug./mg. Incubation of approximately 1 mg. tissue in 0 -4 ml. 150 mM NaCl for 1 hr. at 370 C. did not lower the glycogen concentration, whereas incubation in 0 4 ml. 150 mM NaCl containing 1 mg./ml. oc-glucosidase lowered the glycogen content to 76 ,ug./mg. tissue.
Encouraged by these results we decided to start treatment with oc-glucosidase. The child was then 10 months old, weighed 7 kg., and was in poor condition due to the liver cirrhosis and intestinal haemorrhages. 1 g. o-glucosidase (approximately 18,500 U) was dissolved in 46 ml. sterile pyrogenfree NaCl solution (0 15 M), and sterilized by passage through a Millipore filter. The enzyme solution was injected intravenously twice daily during 4 days and then 3 times daily during 2 days. Altogether the child received 14 injections totalling 56 ml. oc-glucosidase solution containing 1215 mg. enzyme. As can be seen in Fig. 5 , the glycogen concentration of the liver decreased dramatically from 10-7% before the treatment to 1 or 20%. No unfavourable reactions to the treatment were observed. The liver size did not diminish.
Treatment with zinc glucagon. Treatment with oc-glucosidase was followed by treatment with zinc glucagon intramuscularly, with the intention of preventing renewed glycogen accumulation in the liver (Sokal, 1960) : 2 mg. b.d. were given for 2 days, and 1 mg. t.i.d. for the next 25 days. A liver biopsy sample obtained after 24 days of treatment contained 3 O glycogen. The relevant data are shown in Fig. 5 . The effect of this treatment was doubtful: the liver glycogen concentration did not increase significantly, but the child was then in a poor condition.
Discussion
Our data on the activity of branching enzyme in leucocytes confirm the results of Brown and Brown (1966) , so that enzyme determinations in leucocytes provide a useful diagnostic method in 4 of the 6 types of glycogen storage disease, i.e. II, III, IV, and VI, but not I and V (Huijing, 1964 ). An increasing number of inborn errors of metabolism can be diagnosed by means of leucocyte enzyme assays, e.g. Niemann Pick and Gaucher's disease (Kampine et al., 1967) and maple syrup urine disease (Goedde et al., 1967 The fact that the second glucagon test showed no rise of blood glucose, unlike the first test, was not explicable. Liver biopsy obtained four days before the last test showed diffuse cirrhosis, whereas the glycogen content was 10 * 7%. Probably the diminished effect of glucagon was related to the progressive cirrhosis.
The effect of the injected oc-glucosidase in lowering the liver glycogen concentration is in accordance with the findings of Baudhuin et al. (1964) and Cuthbertson et al. (1967) .
Recently Hug and Schubert (1967) reported briefly that purified fungal x-glucosidase decreased the glycogen concentration in the liver of a patient with type II glycogenosis, both in the lysosomes and in the rest of the cytoplasm. The poor clinical result of treatment with a-glucosidase in our patient is not surprising, since the injections were started when the cirrhotic process was already far advanced. The fact that the glycogen concentration of the liver fell dramatically after injections of the enzyme gives some hope that if the enzyme is administered to patients with branching-enzyme deficiency at an earlier stage of the disease, it may prevent accumulation of amylopectin. Obviously such treatment will have to be planned with great care, for the question will arise as to whether occasional large single doses of the enzyme should be given, or whether frequent small doses are less likely to lead to antibody formation. Hug and Schubert (1967) found no antibodies in their patient after 18 days of treatment.
The administration of enzymes parenterally may conceivably prove of value in treating those diseases in which such materials as glycogen, complex lipids, or mucopolysaccharides accumulate.
Summary
The fifth case is reported of glycogen storage disease type IV, characterized by accumulation of an amylopectin-like glycogen and caused by a deficiency of branching enzyme.
The abnormal glycogen and enzyme deficiency were demonstrated in leucocytes when the boy was 6 months old.
